U.S. Banks Stock News

The United States market has remained flat over the last week but is up 16% over the past year, with earnings anticipated to grow by 15% annually. In this environment, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities, particularly when insider activity suggests confidence in a company's future prospects.

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue and earnings expansion in alignment with these broader market trends.

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying stocks that are trading at a discount can offer potential opportunities for investors seeking value in a growing market.

In the last week, the United States market has stayed flat, yet it has risen by 16% over the past year with expectations of a 15% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be advantageous as they often align management interests with shareholder value and may capitalize on favorable market conditions.

The market remained flat over the last week, but it is up 16% over the past year, with earnings expected to grow by 15% annually in the coming years. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value and potential for growth. By focusing on stocks with strong financial foundations, investors may find opportunities that combine stability with promising prospects.

Over the last 7 days, the United States market has remained flat, yet it boasts a notable 16% rise over the past year with earnings forecasted to grow by 15% annually. In such a dynamic environment, discovering promising small-cap stocks that have potential for growth can be key to capitalizing on these positive trends.

Over the last 7 days, the United States market has remained flat, though it has experienced a robust 16% increase over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context of steady growth and positive earnings projections, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking reliable income streams.

We can readily understand why investors are attracted to unprofitable companies. By way of example, Fulcrum...

This article examines whether Olin, at around US$29.73, is attractively valued or already reflects its underlying story by exploring what the current valuation suggests about the stock. The share price performance is mixed, with returns of 7.8% over 7 days, 17.2% over 30 days, 38.0% year to date and 29.5% over 1 year, while longer horizons show a 42.6% decline over 3 years and a 16.9% decline over 5 years. Recent coverage has placed less emphasis on headline-grabbing events and more on how...

Vertiv Holdings Co (VRT) has drawn fresh attention after committing about US$50 million to expand its Ohio manufacturing and headquarters footprint, while analyst rating changes and recent volatility keep investors closely watching the stock. See our latest analysis for Vertiv Holdings Co. Recent trading has been choppy, with a 7.5% 7 day share price return decline and a modest 1 month share price return drop. However, a strong 90 day share price return along with a very large 1 year total...

VICI Properties (VICI) has attracted attention after a recent pullback, with the stock showing a 9.6% decline over the past month and a smaller 2.8% decline over the past 3 months. See our latest analysis for VICI Properties. At a share price of $27.32, VICI’s recent 9.6% 1 month share price return decline and 2.8% 3 month share price return decline sit against a 10.6% 1 year total shareholder return decline and a 22.4% 5 year total shareholder return gain. This suggests near term momentum...

If you are wondering whether Guardian Pharmacy Services at US$37.66 is priced for opportunity or already reflecting high expectations, the valuation picture is the key place to focus next. The stock has posted returns of 0.2% over the last 7 days, 12.4% over the last 30 days, 27.5% year to date and 79.2% over the past year. This naturally raises questions about how much of the story is already in the price. Recent news coverage has centered on Guardian Pharmacy Services as a healthcare name...

With the business potentially at an important milestone, we thought we'd take a closer look at Iterum Therapeutics...

Pfizer (PFE) is back in focus after reporting over 70% efficacy in a Phase 3 Lyme disease vaccine trial and positive Phase 3 results for prostate cancer therapy TALZENNA in combination with XTANDI. See our latest analysis for Pfizer. Positive readouts across vaccines and oncology have coincided with a pick up in momentum, with an 11.5% year to date share price return and a 12.8% 90 day share price return helping lift Pfizer to a 1 year total shareholder return of 22.7% despite weaker 3 and 5...

MSCI (NYSE:MSCI) plans to reclassify Greece from Emerging Market to Developed Market status in its equity indexes. The company is also partnering with Syntax Data to expand its ADR index offerings for financial advisers in the US. These changes affect how global capital is allocated to Greek equities and how advisers access international exposure through US listed securities. MSCI is best known for its global equity indexes that many asset managers and ETFs use as benchmarks, so its country...

In late March 2026, an explosion and fire at Valero Energy’s Port Arthur, Texas refinery injured worker Jonathan Jaimes and prompted a lawsuit alleging unsafe conditions and gross negligence. Although most operations at the 435,000-barrel-per-day refinery were restarted within two days, a key diesel hydrotreater remains offline, highlighting ongoing operational and legal risks tied to the incident. Next, we’ll examine how the Port Arthur explosion, ongoing diesel unit outage, and related...

In March 2026, Signet Jewelers reported fourth-quarter sales of US$2,345.1 million and net income of US$250.0 million, alongside a higher full-year profit, while also raising its quarterly dividend to US$0.35 per share and continuing share repurchases. The sharp year-on-year jump in earnings per share, combined with a nearly double-digit dividend increase and ongoing buybacks, underscores management’s confidence in the company’s financial position and cash-generation capacity. We’ll now...

Invesco (IVZ) is drawing fresh attention after expanding its Invesco QQQ Innovation Suite with the launch of the Invesco QQQ Equal Weight ETF, QEW, which offers equal-weight exposure to Nasdaq-100 companies. See our latest analysis for Invesco. Recent trading reflects mixed momentum, with a 1-day share price return of 4.29% taking Invesco to $24.29. This contrasts with 30-day and year to date share price returns of 7.50% and 9.84% declines, alongside a 1-year total shareholder return of...

Samsara Inc. recently announced its 2026 North America Customer Advisory Board, bringing together senior leaders from major logistics, utilities, construction, and industrial organizations to provide operational insights that inform product development. This board has already influenced offerings like Samsara Coach and the Asset Tag XS and is expected to shape further product innovations informed directly by large enterprise customers’ real-world needs. We’ll now examine how this expanded...

In March 2026, Neurocrine Biosciences presented new expert consensus recommendations and fresh INGREZZA (valbenazine) data on older adults with tardive dyskinesia at the PALTC26 conference in Anaheim, highlighting care challenges in long-term care settings. The company underscored INGREZZA’s differentiated clinical profile for seniors, including no required dose titration and a sprinkle formulation, alongside patient-reported improvements in symptoms, quality of life and functional...

The Morning Bull - US Market Morning Update Wednesday, Apr, 1 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.5% and Nasdaq 100 futures rising roughly 0.7%, as investors react to cooler bond markets and mixed global growth signals. The US 10 year Treasury yield is at 4.28%, which means borrowing costs are still relatively high but not pushing higher, easing some pressure on rate sensitive areas like real estate and smaller companies. At the...

We can readily understand why investors are attracted to unprofitable companies. For example, Annexon ( NASDAQ:ANNX...

Earnings results bring Precigen’s 2025 performance into focus Precigen (PGEN) recently reported full year 2025 results, with revenue of US$9.68 million and a net loss of US$250.64 million. The wider loss and revenue figures are likely central to how investors reassess the stock. See our latest analysis for Precigen. Precigen’s share price has been volatile, with a 1 day share price return of 19.08% and 7 day return of 23.64%, while the 90 day return shows a decline of 7.42%. This contrasts...

Creative Medical Technology Holdings, Inc. ( NASDAQ:CELZ ) is possibly approaching a major achievement in its business...